CROMOLYN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cromolyn, and when can generic versions of Cromolyn launch?
Cromolyn is a drug marketed by Ailex Pharms Llc, Genera Pharms, Micro Labs Ltd India, Rising, Apotex Inc, Sandoz, Sciegen Pharms, Actavis Mid Atlantic, Bausch, Eugia Pharma, Fera Pharms Llc, Hikma, Micro Labs, Roxane, Teva Pharms, Watson Labs, Wockhardt Bio Ag, Bausch And Lomb, Hh And P, and Perrigo. and is included in twenty-two NDAs.
The generic ingredient in CROMOLYN is cromolyn sodium. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the cromolyn sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cromolyn
A generic version of CROMOLYN was approved as cromolyn sodium by SANDOZ on June 16th, 1999.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CROMOLYN?
- What are the global sales for CROMOLYN?
- What is Average Wholesale Price for CROMOLYN?
Summary for CROMOLYN
| US Patents: | 0 |
| Applicants: | 20 |
| NDAs: | 22 |
| Drug Prices: | Drug price information for CROMOLYN |
| DailyMed Link: | CROMOLYN at DailyMed |


